Landos Biopharma, Inc. ROE 2020-2024 | LABP

Current and historical return on equity (ROE) values for Landos Biopharma, Inc. (LABP) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-03-31 $-0.03B $0.02B -73.53%
2023-12-31 $-0.02B $0.03B -55.00%
2023-09-30 $-0.02B $0.04B -50.30%
2023-06-30 $-0.02B $0.04B -53.18%
2023-03-31 $-0.03B $0.05B -65.93%
2022-12-31 $-0.04B $0.04B -79.19%
2022-09-30 $-0.05B $0.04B -92.31%
2022-06-30 $-0.06B $0.05B -83.10%
2022-03-31 $-0.04B $0.06B -52.07%
2021-12-31 $-0.04B $0.08B -41.38%
2021-09-30 $-0.03B $0.09B -48.58%
2021-06-30 $-0.03B $0.11B -65.36%
2021-03-31 $-0.03B $0.10B -289.36%
2020-12-31 $-0.03B $-0.05B 222.22%